-
Je něco špatně v tomto záznamu ?
Autophagy in MCF-7 cancer cells induced by copper complexes
K. Koňariková, GA. Perdikaris, H. Gbelcová, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, S. Režnáková, I. Žitňanová,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články
- MeSH
- autofagie účinky léků fyziologie MeSH
- HEK293 buňky MeSH
- lidé MeSH
- měď farmakologie toxicita MeSH
- MFC-7 buňky MeSH
- myši MeSH
- proliferace buněk účinky léků fyziologie MeSH
- Schiffovy báze farmakologie toxicita MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Autophagy plays an important role in cancer cells. Targeting autophagy in cancer can provide new opportunities for drug development. METHODS: In this study we tested four Schiff base Cu(II) complexes against human breast cancer cells (MCF-7) and human non-cancerous cells (HEK-293T). We have tested their cytotoxic effect by evaluating IC50 using MTT test. To detect morphological changes of the actin fibers we have used fluorescent microscopy. To determine the type of cell death we used electrophoretic analysis and western blot analysis (protein LC3). RESULTS: IC50 values of the complexes increased with time of their influence, indicating acquired resistance of MCF-7 to the complexes. Healthy cells HEK-293T were not sensitive to the Cu(II) complexes. Compared with the control cells (cells without Cu(II) complexes) which were without morphological changes of actin fibers, Cu(II) complexes induced condensation and asymmetric conformational changes in actin filaments. To examine the type of cell death induced by the Cu(II) complexes we treated MCF-7 cells with Cu(II) complexes (1, 10, 50 and 100μmol/L) during a 72h incubation period. By electrophoresis we have not detected any DNA fragmentation. To determine whether Cu(II) complexes induced autophagy or necrotic cell death we used the western blot analysis. MCF-7 cells influenced with tested Cu(II) complexes produced LC3 protein after their 72h incubation indicating autophagy in MCF-7 cancer cells. CONCLUSIONS: Tested Schiff base copper (II) complexes have antiproliferative activity against cancer cells but not against healthy cells. They have induced autophagy in the cancer cell line MCF-7.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013508
- 003
- CZ-PrNML
- 005
- 20170426094451.0
- 007
- ta
- 008
- 170413s2016 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.pharep.2016.07.011 $2 doi
- 035 __
- $a (PubMed)27665074
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Koňariková, Katarína $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
- 245 10
- $a Autophagy in MCF-7 cancer cells induced by copper complexes / $c K. Koňariková, GA. Perdikaris, H. Gbelcová, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, S. Režnáková, I. Žitňanová,
- 520 9_
- $a BACKGROUND: Autophagy plays an important role in cancer cells. Targeting autophagy in cancer can provide new opportunities for drug development. METHODS: In this study we tested four Schiff base Cu(II) complexes against human breast cancer cells (MCF-7) and human non-cancerous cells (HEK-293T). We have tested their cytotoxic effect by evaluating IC50 using MTT test. To detect morphological changes of the actin fibers we have used fluorescent microscopy. To determine the type of cell death we used electrophoretic analysis and western blot analysis (protein LC3). RESULTS: IC50 values of the complexes increased with time of their influence, indicating acquired resistance of MCF-7 to the complexes. Healthy cells HEK-293T were not sensitive to the Cu(II) complexes. Compared with the control cells (cells without Cu(II) complexes) which were without morphological changes of actin fibers, Cu(II) complexes induced condensation and asymmetric conformational changes in actin filaments. To examine the type of cell death induced by the Cu(II) complexes we treated MCF-7 cells with Cu(II) complexes (1, 10, 50 and 100μmol/L) during a 72h incubation period. By electrophoresis we have not detected any DNA fragmentation. To determine whether Cu(II) complexes induced autophagy or necrotic cell death we used the western blot analysis. MCF-7 cells influenced with tested Cu(II) complexes produced LC3 protein after their 72h incubation indicating autophagy in MCF-7 cancer cells. CONCLUSIONS: Tested Schiff base copper (II) complexes have antiproliferative activity against cancer cells but not against healthy cells. They have induced autophagy in the cancer cell line MCF-7.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a autofagie $x účinky léků $x fyziologie $7 D001343
- 650 _2
- $a proliferace buněk $x účinky léků $x fyziologie $7 D049109
- 650 _2
- $a měď $x farmakologie $x toxicita $7 D003300
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a MFC-7 buňky $7 D061986
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a Schiffovy báze $x farmakologie $x toxicita $7 D012545
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Perdikaris, Georgios A $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
- 700 1_
- $a Gbelcová, Helena $u Institute of Medical Biology and Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
- 700 1_
- $a Andrezálová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. $7 gn_A_00006628
- 700 1_
- $a Švéda, Martin $u Institute of Chemical Technology, Department of Biochemistry and Microbiology, Faculty of Food Biochemical Technology, Technicka 5, 166 28, Prague, Czech Republic.
- 700 1_
- $a Ruml, Tomáš $u Institute of Chemical Technology, Department of Biochemistry and Microbiology, Faculty of Food Biochemical Technology, Technicka 5, 166 28, Prague, Czech Republic.
- 700 1_
- $a Laubertová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
- 700 1_
- $a Režnáková, Soňa $u Institute of Medical Biology and Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
- 700 1_
- $a Žitňanová, Ingrid $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. Electronic address: ingrid.zitnanova@fmed.uniba.sk.
- 773 0_
- $w MED00165879 $t Pharmacological reports PR $x 1734-1140 $g Roč. 68, č. 6 (2016), s. 1221-1224
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27665074 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170426094809 $b ABA008
- 999 __
- $a ok $b bmc $g 1199973 $s 974286
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 68 $c 6 $d 1221-1224 $e 20160730 $i 1734-1140 $m Pharmacol. Reports $n Pharmacol. Rep. $x MED00165879
- LZP __
- $a Pubmed-20170413